SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

14 Aug 2023 Evaluate
The sales for the June 2023 quarter moved down -36.34% to Rs. 986.30 millions as compared to Rs. 1549.30 millions during the year ago period.A big decline of -60.87% was reported for the quarter ended June 2023 to Rs. 43.40  millions from Rs. 110.90 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 155.30 millions from 196.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 986.30 1549.30 -36.34 986.30 1549.30 -36.34 5376.60 5767.10 -6.77
Other Income 20.60 14.10 46.10 20.60 14.10 46.10 101.70 84.30 20.64
PBIDT 155.30 196.60 -21.01 155.30 196.60 -21.01 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 155.30 196.60 -21.01 155.30 196.60 -21.01 717.00 772.50 -7.18
Depreciation 73.20 75.70 -3.30 73.20 75.70 -3.30 313.70 325.80 -3.71
PBT 82.10 120.90 -32.09 82.10 120.90 -32.09 403.30 446.70 -9.72
TAX 38.70 10.00 287.00 38.70 10.00 287.00 113.70 -43.20 -363.19
Deferred Tax 4.80 10.00 -52.00 4.80 10.00 -52.00 113.70 -43.20 -363.19
PAT 43.40 110.90 -60.87 43.40 110.90 -60.87 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 15.75 12.69 24.08 15.75 12.69 24.08 13.34 13.39 -0.44

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×